Human Relaxin-2 (Serelaxin) Attenuates Oxidative Stress in Cardiac Muscle Cells Exposed In Vitro to Hypoxia–Reoxygenation. Evidence for the Involvement of Reduced Glutathione Up-Regulation

Serelaxin (RLX) designates the pharmaceutical form of the human natural hormone relaxin-2 that has been shown to markedly reduce tissue and cell damage induced by hypoxia and reoxygenation (HR). The evidence that RLX exerts similar protective effects on different organs and cells at relatively low,...

Descripción completa

Detalles Bibliográficos
Autores principales: Nistri, Silvia, Fiorillo, Claudia, Becatti, Matteo, Bani, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555919/
https://www.ncbi.nlm.nih.gov/pubmed/32825567
http://dx.doi.org/10.3390/antiox9090774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555919/
https://www.ncbi.nlm.nih.gov/pubmed/32825567
http://dx.doi.org/10.3390/antiox9090774

Ejemplares similares